Bioniche Life Sciences Inc. 25 Years
Contact Us Careers
Home Investors
In the News

December 21, 2011
Bioniche Life Sciences Inc. Enters into Two Distribution Agreements for New Animal Health Products

December 13, 2011
Bioniche E. coli Vaccine Granted Import Access to Australia

Investors

Latest TSX stock price

All prices delayed at least 15 minutes.
Source: TSX Inc.

Latest ASX stock price

All prices delayed at least 20 minutes.
Source: ASX Inc.


Shareholder Information

Inquiries related to stock transfer, lost certificates or address changes should be directed to our Transfer Agent, CIBC Mellon Trust Company.

Contact information:

CIBC Mellon Trust Company
P.O. Box 7010
Adelaide St. Postal Station
Toronto, Ontario M5C 2W9
Tel: (416) 643-5500
Toll free: (800) 387-0825
Fax: (416) 643-5501
E-mail: inquiries@cibcmellon.com

Bioniche financial reports can be downloaded here

Request investor materials by regular mail here

All Bioniche publicly-listed documents can be viewed here

E-mail Alerts

To automatically receive an e-mail alert when Bioniche news releases are posted to this site, enter your e-mail address here.

Copyright 2004, Bioniche Life Sciences Inc. All rights reserved  |  Legal Disclaimer  |  Privacy Policy